Neuroblastoma of the adrenal gland in children

Authors

  • Gudumac Eva Catedra de chirurgie, ortopedie și anesteziologie pediatrică „Natalia Gheorghiu”, USMF „Nicolae Testemițanu”
  • Bernic Jana Catedra de chirurgie, ortopedie și anesteziologie pediatrică „Natalia Gheorghiu”, USMF „Nicolae Testemițanu”
  • Roller Victor Catedra de chirurgie, ortopedie și anesteziologie pediatrică „Natalia Gheorghiu”, USMF „Nicolae Testemițanu”
  • Lisiţa Natalia Institutul Oncologic, secția Pediatrie oncologică
  • Costiuc Ecaterina Catedra de chirurgie, ortopedie și anesteziologie pediatrică „Natalia Gheorghiu”, USMF „Nicolae Testemițanu”

DOI:

https://doi.org/10.52692/1857-0011.2021.2-70.03

Keywords:

neuroblastoma, adrenal gland, child

Abstract

The study includes a complex retrospective, analysis of medical records, clinical, imaging, morphopathological, laboratory observations and the results of surgical treatment of a series of patients from 0 and 13 months respectively with the diagnosis of Neuroblastoma of the adrenal gland, investigated and treated in „Natalia Gheorghiu” National Scientific and Practical Center for Pediatric Surgery of the Mother and Child Institute. Clinical and paraclinical data are elucidated consecutively in 5 patients and then they are compared with a case published by NCI (National Cancer Institute)

Author Biographies

Gudumac Eva, Catedra de chirurgie, ortopedie și anesteziologie pediatrică „Natalia Gheorghiu”, USMF „Nicolae Testemițanu”

dr. hab. șt. med., prof. univ., acad. AȘM

Bernic Jana, Catedra de chirurgie, ortopedie și anesteziologie pediatrică „Natalia Gheorghiu”, USMF „Nicolae Testemițanu”

dr. hab. șt. med., prof. univ

Roller Victor, Catedra de chirurgie, ortopedie și anesteziologie pediatrică „Natalia Gheorghiu”, USMF „Nicolae Testemițanu”

asist. univ

Costiuc Ecaterina, Catedra de chirurgie, ortopedie și anesteziologie pediatrică „Natalia Gheorghiu”, USMF „Nicolae Testemițanu”

medic rezident

References

Brodeur G.M., Minturn J.E., Ho R., et al. Trk receptor expression and inhibition in neuroblastomas. Clin. Cancer Res., 2009; 15(10):3244-50.

Cohn S.L., Pearson A.D., London W.B., et al. The International Neuroblastom Risk Goup (INRG) classification system: an INRG Task Force report. J. Clin Oncol. 2009; 27(2): 89-97.

Campbell K., Gastier-Foster J.M., Mann M. et al. Asociation of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children’s Oncology Group. Cancer 2017; 123(21):4224-4235.

Howlader N., Noone A.M., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2009 (Vintajge 2009 Populations). Bethesda, Md: National Cancer Institute, 2012; 26(4):177-84.

Smith M.A., Altekruse S.F., Adamson P.C., et al. Declining childhood and adolescent cancer mortality. Cancer 2014; 120(16):2497-506.

Strother D.R., London W.B., Schimidt M.L. et al. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children’s Oncology Group study P9641. J. Clin. Oncol., 2012; 30(15):1842-8.

https://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq/link/_942 [last accessed on 2018 Dec 16].

Published

2021-06-25